ESPR Operating Cash Flow (Statement)
Esperion Therapeutics Inc · Operating Cash Flow (Statement)
ESPR Operating Cash Flow (Statement)
Latest reported-$18.19Mperiod ending
ESPR TTM Cash from Operations (-$17.95M → -$18.19M)
TTM operating cash flow (statement)
High-resolution chart · PNG
ESPR operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -18,187,000 | |
| -13,093,000 | |
| -93,288,000 | |
| -124,327,000 | |
| -100,110,000 | |
| -23,654,000 | |
| -25,758,000 | |
| -9,758,000 | |
| -27,303,000 | |
| -135,487,000 | |
| -140,684,000 | |
| -164,411,000 | |
| -190,193,000 | |
| -174,827,000 | |
| -190,280,000 | |
| -216,397,000 | |
| -213,731,000 | |
| -263,809,000 | |
| -274,653,000 | |
| -292,155,000 | |
| -104,898,000 | |
| -85,177,000 | |
| -66,621,000 | |
| -37,979,000 | |
| -231,379,000 | |
| -70,341,000 | |
| -49,039,000 | |
| -28,537,000 | |
| -13,726,000 | |
| -148,638,000 | |
| -154,820,000 | |
| -153,177,000 | |
| -140,207,000 | |
| -131,302,000 | |
| -112,744,000 | |
| -91,164,000 | |
| -72,243,000 | |
| -47,730,000 | |
| -39,863,000 | |
| -37,389,000 | |
| -38,696,000 | |
| -38,156,000 | |
| -37,915,000 | |
| -34,716,000 | |
| -32,180,000 | |
| -32,021,000 | |
| -31,343,349 | |
| -27,489,245 | |
| -24,590,791 | |
| -18,113,361 | |
| -12,952,816 | |
| -11,082,084 | |
| -10,749,632 | |
| -10,808,567 | |
| -15,601,763 | |
| -18,784,599 | |
| -22,911,505 | |
| -25,841,000 | |
| -25,363,000 | |
| -26,280,000 | |
| -26,564,000 | |
| -26,983,000 | |
| -25,544,000 | |
| -24,385,000 | |
| -22,767,000 | |
| -22,475,000 | |
| -20,553,000 | |
| -19,205,396 | |
| -17,954,000 |